This page was exported from International Journal Of Pathology [ ]
Export date: Sun Nov 28 0:03:13 2021 / +0000 GMT

CYCLOOXYGENASE -2 AND CANCER: A silent link with fatal ending.

Salman Zafar*, Shahnaz Imdad Kehar**

Department of Pathology, Basic Medical Sciences Institute Jinnah Postgraduate Medical College Karachi


Remarkable evolutions in pathogenic role of Cyclooxygenase-2 (COX-2) in tumorigenesis have diverted

the cancer research in the direction of COX-2 inhibitors. An expanding body of evidence indicates that down

regulation of cyclooxygenase 2 will be an important strategy for preventing cancer because COX-2 catalyzes the

formation of prostaglandins(PGs) and these prostaglandins have multiple effects that favor tumorigenesis. It is

proved that during the process of chronic inflammation several cytokines and inflammatory mediators are released

which act during the different stages of carcinogenesis. Among all these mediators COX 2 are the key player. COX2

is found to be over expressed in several malignancies like colorectal carcinoma, squamous cell carcinomas of head

and neck, carcinomas of urinary bladder, liver, stomach, breast as well as hematological malignancies. Our review

article aims to summarize the role of COX 2 in various cancers and the mechanisms responsible for carcinogenesis.

The informations gathered in this review are taken mainly from articles published in different international


Key Words: COX-2 Cyclooxygenase 2.



Post date: 2016-03-05 02:16:20
Post date GMT: 2016-03-05 02:16:20
Post modified date: 2016-03-05 02:16:20
Post modified date GMT: 2016-03-05 02:16:20

Powered by [ Universal Post Manager ] plugin. MS Word saving format developed by gVectors Team